Neuroprotective action of genipin on tunicamycin-induced cytotoxicity in neuro2a cells

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 7, 2009, Pages 1220-1223

  Tanaka, Masayuki ^a,b   Yamazaki, Matsumi ^a   Chiba, Kenzo ^a  

^a HOKURIKU UNIVERSITY   (Japan)

^b INSTITUTE FOR DEVELOPMENTAL RESEARCH   (Japan)

Author keywords

Endoplasmic reticulum stress; Genipin; Neuro2a cell; Neuroprotection; Tunicamycin

Indexed keywords

CASPASE 12; GENIPIN; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MESSENGER RNA; PROTEIN KINASE; PROTEIN KINASE LIKE ENDOPLASMIC RETICULUM KINASE; TUNICAMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN INDUCTION; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CASPASE 12; CCAAT-ENHANCER-BINDING PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPLASMIC RETICULUM; HEAT-SHOCK PROTEINS; IRIDOIDS; MICE; NEUROPROTECTIVE AGENTS; PROTEIN FOLDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR CHOP; TUNICAMYCIN;

EID: 67650751098     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1220     Document Type: Article

References (23)

1. Kaufman R. J., Gene Dev., 13, 1211-1233 (1999).
2. Ron D., J. Clin. Invest., 110, 1383-1388 (2002).
3. Rao R. V., Ellerby H. M., Bredesen D. E., Cell Death Differ., 11, 372-380 (2004).
4. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B. A., Yuan J., Nature (London), 403, 98-103 (2000).
5. Szegezdi E., Fitzgerald U., Samali A., Ann. N. Y. Acad. Sci., 1010, 186-194 (2003).
6. Forloni G., Terreni L., Bertani I., Fogliarino S., Invernizzi R., Assini A., Ribizzi G., Negro A., Calabrese E., Volonte M. A., Mariani C., Franceschi M., Tabaton M., Bertoli A., Neurobiol. Aging, 23, 957-976 (2002).
7. Shastry B. S., Neurochem. Int., 34, 1-7 (2003).
8. Oyadomari S., Mori M., Cell Death Differ., 11, 381-389 (2004).
9. Hunng E. J., Reichardt L. F., Annu. Rev. Neurosci., 24, 677-736 (2001).
10. Hsu H. Y., Yang J. J., Lin S. Y., Lin C. C., Cancer Lett., 113, 31-37 (1997).
11. Ishiguro K., Yamaki M., Takayi S., J. Nat. Prod., 46, 532-536 (1983).
12. Miyagoshi M., Amagaya S., Orihara R., J. Pharmacobiodyn., 11, 186-190 (1988).
13. Circosta C., Occhiuto F., Ragusa S., Trovato A., Tumono G., Brigurio F., De Pasqule A., J. Ethnopharmacol., 11, 259-274 (1984).
14. Chang I. M., Res. Commun. Mol. Pathol. Pharmacol., 102, 189-204 (1998).
15. Yamazaki M., Chiba K., Mohri T., Biol. Pharm. Bull., 19, 791-795 (1996).
16. Yamazaki M., Sakura K., Chiba K., Mohri T., Biol. Pharm. Bull., 24, 1454-1455 (2001).
17. Yamazaki M., Chiba K., Satoh K., J. Health Sci., 54, 638-644 (2008).
18. Bradford M. M., Anal. Biochem., 72, 248-254 (1976).
19. Breckenridge D. G., Germain M., Mathai J. P., Nguyuen M., Shore G. C., Oncogene, 22, 8608-8618 (2003).
20. Price B. D., Mannheim-Rodman L. A., Calderwood S. K., J. Cell Physiol., 152, 545-552 (1992).
21. Rao R. V., Hermel E., Castro-Obregon S., del Rio G., Ellerby L. M., Ellerby H. M., Bredesen D. E., J. Biol. Chem., 276, 33869-33874 (2001).
22. Fischer H., Koenig U., Eckhart L., Tschachler E., Biochem. Biophys. Res. Commun., 293, 722-726 (2002).
23. Hitomi J., Katayama T., Eguchi Y., Kudo T., Taniguchi M., Koyama Y., Manabe T., Yamagishi S., Bando Y., Imaizumi K., Tsujimoto Y., Tohyama M., J. Cell Biol., 165, 347-356 (2004).